␣ 1 -Microglobulin is a 26-kd protein, widespread in plasma and tissues and wellconserved among vertebrates. ␣ 1 -Microglobulin belongs to the lipocalins, a protein superfamily with highly conserved 3-dimensional structures, forming an internal ligand binding pocket. The protein, isolated from urine, has a heterogeneous yellow-brown chromophore bound covalently to amino acid side groups around the entrance of the lipocalin pocket. ␣ 1 -Microglobulin is found in blood both in free form and complex-bound to immunoglobulin A (IgA) via a half-cystine residue at position 34. It is shown here that an ␣ 1 -microglobulin species, which we name t-␣ 1 -microglobulin (t ‫؍‬ truncated), with a free Cys34 thiol group, lacking its Cterminal tetrapeptide, LIPR, and with a more polar environment around the entrance of the lipocalin pocket, is released from IgA-␣ 1 -microglobulin as well as from free ␣ 1 -microglobulin when exposed to the cytosolic side of erythrocyte membranes or to purified oxyhemoglobin. 
Introduction
Hemoglobin, the major oxygen carrier system in the blood, has a number of toxic, potentially dangerous side effects. 1, 2 Most of these have their origin in the auto-oxidation of oxyhemoglobin. Hemoglobin is a tetramer consisting of 4 globin subunits (␣ 2 ␤ 2 ), each carrying a heme group in its active center. 3 Heme consists of protoporphyrin IX and a ferrous (Fe 2ϩ ) iron atom which has high affinity for free oxygen (O 2 ). Ferrous hemoglobin binding to O 2 is called oxyhemoglobin. Auto-oxidation of oxyhemoglobin is a spontaneous intramolecular oxidation-reduction reaction eventually leading to production of ferric (Fe 3ϩ ) hemoglobin (methemoglobin), ferryl (Fe 4ϩ ) hemoglobin, free heme ("heme" and "hemin" are sometimes used to designate free protoporphyrin IX with a bound Fe 2ϩ or Fe 3ϩ atom, respectively; in this article, "heme" is used regardless of the iron oxidation state), and various reactive oxygen species, including free radicals. 4 These compounds present considerable oxidative stress, leading to tissue damage and cell destruction.
The overwhelming part of hemoglobin is found strictly compartmentalized within erythrocytes. The auto-oxidation of oxyhemoglobin and downstream free-radical formation is largely prevented by the intracellular inhibitors superoxide dismutase, catalase, and glutathione peroxidase. 5, 6 In spite of this, slow auto-oxidation occurs intracellularly. Oxidized hemoglobin forms which are unstable and easily denatured are found deposited together with free heme and iron on the cytosolic face of the erythrocyte membrane. 7 Hemoglobin is also found extracellularly in plasma at normal concentrations up to around 5 mg/L, mainly as a result of hemolysis. 8 Plasma contains haptoglobin, 9 a high-affinity binder of oxyhemoglobin and inhibitor of auto-oxidation; iron-and hemebinding proteins such as transferrin, albumin, and hemopexin; and antioxidants such as vitamin E and ascorbic acid. However, it is generally agreed that these systems are not sufficient to protect against hemoglobin-mediated oxidative cell and tissue damage during increased extravascular hemolysis and general hemolytic pathologic disorders.
␣ 1 -Microglobulin (␣ 1 m) is a plasma and tissue protein with unknown biologic functions. It is evolutionarily well-conserved and has so far been found in mammals, birds, fish, and amphibians. ␣ 1 m is a glycoprotein with a relatively low molecular mass, 26 kd. 10 Hence, it is filtered through the glomerular membranes of the kidney and was originally isolated from urine. 11 ␣ 1 m, also called protein HC, 12 has many intriguing properties. 13, 14 It belongs to the lipocalin superfamily, a group of proteins from animals, plants, and bacteria with a well-conserved 3-dimensional structure. The lipocalins consist of a 160 to 190 amino-acid polypeptide folded into an 8-stranded ␤-barrel surrounding a pocket that can bind hydrophobic ligands. 15 The ligand of ␣ 1 m is unidentified. ␣ 1 m carries an extremely heterogeneous yellow-brown chromophore, covalently bound to lysyl residues (Lys 92, 118, and 130) surrounding the entrance of the lipocalin pocket. 16 ␣ 1 m has one unpaired cysteine residue (Cys 34) which can interact with a second free Cys exposed at the surface of other proteins. Thus, a circulating covalent complex between ␣ 1 m and immunoglobulin A (IgA), involving about 50% of plasma-␣ 1 m, was shown to be mediated by Cys 34 of ␣ 1 m and the penultimate Cys residue of the IgA ␣-chain. 17 The Cys-Cys interchain cross-link of IgA-␣ 1 m has so far been impossible to reduce in vitro. Therefore, the original observation of this work, the cleavage of IgA-␣ 1 m into free ␣ 1 m and IgA by ruptured erythrocytes, was surprising. It prompted an investigation of the role of ␣ 1 m in hemolysis. The results indicate that an activated form of ␣ 1 m, which participates in degradation of heme, is released from free ␣ 1 m and its IgA complex by exposed erythrocyte membranes and hemoglobin. The results suggest a possible biologic function of ␣ 1 m in protection against unsequestered heme/hemoglobin that could explain its widespread distribution in tissues and species as well as some of its enigmatic biochemical properties.
Materials and methods

Proteins and reagents
Urine and blood from apparently healthy donors and urine from patients were collected. Information about the medical condition and serologic data for the patient and control groups was obtained from the Hematology Department and Blood Center at the University Hospital in Lund, Sweden. Approval was obtained from the institutional review board for these studies. Informed consent was provided according to the Declaration of Helsinki. Blood was drawn with addition of heparin anticoagulant. The urine and plasma, prepared from the blood, were frozen at Ϫ30°C within 1 hour. Oxyhemoglobin was prepared by diethylaminoethyl (DEAE)-Sephadex ion-exchange chromatography of erythrocyte hemolysates according to Winterbourn. 4 IgA-␣ 1 m, plasma-␣ 1 m, urine ␣ 1 m, and pepsin-␣ 1 m were purified in our laboratory as described earlier. 16, 18, 19 Rabbit anti-␣ 1 m was prepared by immunization with urine ␣ 1 m as described. 20 Rabbit anti-LIPR was prepared by AgriSera AB (Vännäs, Sweden) by immunization with the synthetic peptide CKKLIPR conjugated to keyhole limpet hemocyanin (KLH). Mouse monoclonal anti-␣ 1 m, BN11.10, was prepared and purified as described 21 and immobilized to Affigel Hz (Bio-Rad Labs, Hercules, CA) at 20 mg/mL, following instructions from the manufacturer. Goat antihuman heme oxygenase I (cat. no. sc-1796) was from Santa Cruz Biotechnology (Santa Cruz, CA). Orosomucoid, ovalbumin, and human serum albumin were purchased from Sigma Chemicals (St Louis, MO).
Erythrocytes and membranes
Blood was centrifuged at 1200g for 10 minutes, plasma-and buffy coat-aspirated, and the red blood cells washed 4 times with 10 volumes of phosphate buffered saline (PBS): 10 mM phosphate buffer, pH 7.4, 120 mM NaCl, 3 mM KCl. The packed erythrocytes were lysed by resuspension in 1 volume of cold, hypotonic buffer (H 2 O:PBS, 20:1) on ice. Membrane pellets were separated from cytosol by centrifuging the lysed suspension at 14 000g for 20 minutes with subsequent washing. The pellets were then resuspended in PBS to one-tenth of the original blood volume. Hemoglobinfree membranes were prepared by repeated washing as described by Dodge et al. 22 Membrane proteins were quantitated by the BCA Protein Assay Kit (Pierce, Rockford, IL). For further fractionation of membrane constituents, the lysed erythrocytes were centrifuged at 32 000g for 30 minutes, the membrane pellet solubilized in 50 mM Tris-HCl, pH 8.0 ϩ 1% Nonidet P-40, and centrifuged at 8000g for 10 minutes. The supernatant was then applied to Sephacryl S-300 gel chromatography, eluting with 20 mM Tris-HCl, pH 8.0, 0.15 M NaCl, and 0.02% NaN 3 , and analyzing the eluted fractions for ultraviolet (UV) absorbance and ␣ 1 m cleavage activity as described below. 
Heme binding experiments
The binding of heme by ␣ 1 m was studied by incubation with (1) methemoglobin-Sepharose, (2) purified oxyhemoglobin, and (3) [ 14 C]heme. Oxyhemoglobin was immobilized to CNBr-activated Sepharose 4B at 10 mg/mL (Amersham Pharmacia Biotech, Uppsala, Sweden) according to the description from the manufacturer and with modifications made by Gattoni et al. 23 The immobilized oxyhemoglobin was oxidized to the ferric form (methemoglobin) by incubating with 1.2 equivalents of potassium ferricyanide (K 3 Fe[CN] 6 ) at room temperature for 30 minutes and then washed extensively with 0.1 M phosphate buffer, pH 7.4. MethemoglobinSepharose was incubated with ␣ 1 m or control proteins in PBS. The reaction proceeded for 60 minutes at room temperature with careful agitation and was terminated by pelleting the hemoglobin-Sepharose and removing the supernatants for absorbance spectrum analysis. Oxyhemoglobin (7 M) and ␣ 1 m or control proteins (5 M) were incubated in PBS at 37°C for 1 hour. ␣ 1 m was purified by affinity chromatography on a column of monoclonal anti-␣ 1 m Affigel, concentrated and analyzed by spectrophotometry. ␣ 1 m or control proteins (0.1 nmol-0.2 nmol) in 10 L PBS were incubated with 25 pmol [ 14 C]heme diluted in PBS plus 1% Tween-20. The incubation was performed at room temperature in dim light. The reaction was stopped at different time intervals by adding SDS-PAGE sample buffer, separating by SDS-PAGE, staining, and phosphoimaging analysis (see below).
Heme degradation
Oxyhemoglobin (3 M) was incubated alone or with t-␣ 1 m or control proteins (24 M) in 20 mM phosphate buffer, pH 7.4, at 37°C. The absorbance at 410 nm was read at 5-minute intervals for up to 24 hours, blanking with the reaction solutions themselves at time zero.
Preparation of [ 14 C]heme
Radiolabeled, 14 C-substituted heme was produced using the E coli strain AN344 containing the plasmid pTYR13. This strain/plasmid combination (kindly donated by Dr Lars Hederstedt, Department of Microbiology, Lund University) requires the heme-precursor ␦-aminolevulinic acid (ALA) for growth and was cultured with LB-medium (10 g/L Tryptone-Peptone, Difco, Becton Dickinson, Sparks, MD, 5 g/L yeast extract, Merck, Darmstadt, Germany, 5 g/L sodium chloride) containing [4-14 C]ALA, 50 Ci/mol (New England Nuclear, Boston, MA) as described by Schiött et al. 24 The yield of [ 14 C]heme was about 20 nmol per 60-mL culture with a specific activity of 2.5 Ci/mmol (90GBq/mmol).
Gel electrophoresis and immunoblotting
SDS-PAGE was performed using either 10% or 12% slab gels in the buffer system described by Laemmli, 25 sometimes including 2% vol/vol ␤-mercaptoethanol in the sample buffers. High-molecular-mass standards (rainbow markers; Amersham Pharmacia Biotech, Uppsala, Sweden) were used. The polyacrylamide gels were stained with Coomassie Brilliant Blue R-250 and in some cases dried. For immunoblotting, the gels were transferred to polyvinylidenefluoride (PVDF) membranes (Immobilon, Millipore, Bedford, MA) as described. 26 The membranes were then incubated with antiserum as previously described. 27 Radioactive samples ( 14 C or 125 I) in dried gels and membranes were analyzed by phosphoimaging in a Fujix BAS 2000 Bioimaging analyzer (Fujifilm Sverige AB, Stockholm, Sweden).
Protein radiolabeling
Proteins were labeled with 125 I (Svensk Radiofarmaka AB, Stockholm, Sweden) using the chloramine-T method. 28 The labeled proteins were separated from free iodide by desalting the reaction mixture on prepacked 9-mL Sephadex G-25 columns (PD10, Amersham Pharmacia Biotech). The specific activity of the labeled proteins was approximately 14 Ci(0.5 MBq)/g protein.
Spectrophotometric methods
Absorbance spectra were measured on a Beckman (Beckman Instruments, Fullerton, CA) DU 640i spectrophotometer using a scan rate of 240 nm/minute and protein concentrations between 1 M and 50 M. Fluorescence spectra were recorded with a Perkin Elmer (Sollentuna, Sweden) LB50 fluorescence spectrometer. The excitation was made at 280 nm with an excitation slit-width of 5 nm and an emission slit-width of 3 nm. The scan speed was 150 nm/minute. The proteins used in this experiment were diluted with PBS to a concentration of 4 M.
Carbohydrate analysis of ␣ 1 -microglobulin
Detection of O-linked and N-linked oligosaccharides was done by glycosidase cleavage and lectin blotting as described. 18 
Amino acid sequence analysis
Amino acid sequencing was done by Dr Bo Ek at Statens Lantbruksuniversitet, Uppsala, Sweden. Briefly, proteins were separated by SDS-PAGE, specific bands cut from the gel and digested by trypsin incubation. Trypsin digests were characterized by electrospray tandem mass spectrometry. This made it possible to make identifications based both on peptide mass data as well as on sequence information (peptide fragmentation data). All measurements were made on a Q-tof instrument (Micromass, Manchester, United Kingdom) essentially according to the manufacturer's instructions.
Alkylation with iodo[ 14 C] acetamide
Proteins were incubated with iodo 
Gel chromatography
Proteins were separated by gel chromatography on a 50-mL Sephacryl S-300 column (Pharmacia, Uppsala, Sweden), equilibrated with 20 mM Tris-HCl, 150 mM NaCl, 0.02% NaN 3, pH 8.0, at 4°C. The column was eluted at a flow rate 12 mL/hour and the eluted fractions were analyzed by absorbance at 280 nm and 410 nm.
Results
Cleavage of ␣ 1 -microglobulin by erythrocyte membranes and hemoglobin
Incubation of free plasma-␣ 1 m with lysed erythrocytes, or the membrane or cytosolic fractions separately, resulted in a reduction in size of the protein when analyzed by SDS-PAGE. The truncated form of ␣ 1 m, which we henceforth call t-␣ 1 m, had an apparent molecular mass of 30 kd, approximately 3 kd less than uncleaved ␣ 1 m (Figure 1) . The IgA-␣ 1 m complex was also cleaved by the erythrocyte fractions. In this complex ␣ 1 m is covalently crosslinked by a nonreducible disulfide bond to one of the heavy (␣)-chains of IgA. The IgA-␣ 1 m complex appears as 3 major bands on SDS-PAGE: the 90-kd ␣ 1 m-␣-chain, the 60-kd ␣-chain, and the 25-kd light chain. In addition, various less-abundant high-molecularweight bands can be seen, representing polymeric forms of IgA-␣ 1 m containing the 90-kd IgA-␣ 1 m-␣-chain component. After incubation with the erythrocyte fractions, the 90-kd IgA-␣-chain band disappeared, and was replaced by free ␣ 1 m with a molecular mass of 30 kd, that is, t-␣ 1 m (Figure 1 ). The same incubation conditions did not affect the migration of control proteins orosomucoid (Figure 1 ), human serum albumin, IgG, IgA, and ovalbumin (not shown) upon SDS-PAGE. Cleavage of ␣ 1 m and IgA-␣ 1 m was achieved using up to 80 nmol protein/mL erythrocytes. The cleavage could be detected after purification by anti-␣ 1 m affinity chromatography followed by SDS-PAGE (see below), by Western blotting of the erythrocyte/␣ 1 m mixture, or by using 125 I-labeled protein (see "Materials and methods").
Erythrocytes were lysed and separated by centrifugation into membrane and cytosolic fractions that were suspended in the original blood cell volume. As stated above, both fractions cleaved plasma-␣ 1 m into t-␣ 1 m. Whole, nonruptured erythrocytes had no cleaving activity at all. Gel filtration on Sephacryl S-300 of solubilized membranes showed that the cleaving activity was associated with medium-sized molecules (not shown). Hemoglobin Plasma-␣1m, IgA-␣1m, and orosomucoid were incubated with purified erythrocyte membranes for 2 hours at 37°C. A quantity of 1 g to 3 g of each protein was separated by SDS-PAGE (T ϭ 12%, C ϭ 3.3%) without prior affinity chromatography purification of the ␣1m-components and stained with Coomassie Brilliant Blue. Lane 1 shows the proteins alone and lane 2 shows the proteins with added erythrocyte membranes. The electrophoresis was performed in the presence of mercaptoethanol. Molecular masses of standards are given in kilodaltons.
is a major macromolecular constituent of both the cytosolic and membrane portions of the lysed erythrocytes. Therefore, we also tested cleaving of ␣ 1 m by purified hemoglobin. Mixing oxyhemoglobin with plasma-␣ 1 m resulted in the same decrease in size as the erythrocyte fractions (Figure 2A ). The specific cleaving activity was estimated by dilution of the membrane and cytosolic fractions and purified hemoglobin (hemoglobin tetramer concentration 0.02 mM, 4 mM, and 1 mM, respectively). The membrane fraction had much higher specific cleaving activity than the other 2; that is, t-␣ 1 m was formed from plasma-␣ 1 m by the membranes at more than 10-fold higher dilution than the cytosol or purified hemoglobin. Hemoglobin-free membranes had no cleaving activity (not shown). These results suggest that hemoglobin in synergy with unknown factors in erythrocyte membranes, alternatively a minor form of hemoglobin found enriched in erythrocyte membranes, mediate the cleavage of ␣ 1 m.
C-terminal proteolysis of ␣ 1 -microglobulin
The t-␣ 1 m formed by cleavage of plasma, recombinant, or IgA-␣ 1 m was purified by applying the mixture of ␣ 1 m and lysed erythrocytes or hemoglobin to a column of immobilized monoclonal antibodies against ␣ 1 m followed by gel chromatography on Sephacryl S-300 ( Figure 2, lanes 2 and 4, respectively) . Hemoglobin was coeluted with ␣ 1 m from the anti-␣ 1 m column but was removed by the gel chromatography step. The cleavage of IgA-␣ 1 m yielded an intact IgA molecule, besides t-␣ 1 m, as judged by SDS-PAGE (eg, Figure 1) or Sephacryl S-300, underscoring the specificity of the cleavage mechanism. The amino acid sequence of purified t-␣ 1 m was analyzed by trypsin cleavage followed by mass spectrometry, and it was shown that ␣ 1 m was cleaved C-terminally; that is, the C-terminal tetrapeptide LIPR (amino acid pos. 180-183) was missing in t-␣ 1 m whether it was produced from free plasma-␣ 1 m or IgA-␣ 1 m, whereas the N-terminus was intact (Table 1) . Polyclonal rabbit antibodies were raised against the synthetic peptide LIPR and used to confirm the absence of the tetrapeptide in t-␣ 1 m. Thus, after SDS-PAGE and blotting, anti-LIPR recognized intact full-length ␣ 1 m but not t-␣ 1 m (Figure 2C ), whereas a conventional anti-␣ 1 m antiserum recognized both intact, fulllength ␣ 1 m and t-␣ 1 m ( Figure 2B) .
The time course of the cleavage of plasma-␣ 1 m by lysed erythrocytes and erythrocyte membranes was studied by SDS-PAGE followed by blotting with anti-␣ 1 m and anti-LIPR ( Figure  3) . The results shows that the cleavage by erythrocyte membranes was completed after 5 minutes.
The results thus suggest that the C-terminal tetrapeptide of ␣ 1 m is released from plasma-␣ 1 m and the IgA-␣ 1 m complex when exposed to hemoglobin and other unknown factors of the cytosol and cytosolic surface of erythrocyte membranes.
Biochemical properties of t-␣ 1 -microglobulin
Characterization of purified t-␣ 1 m from plasma-␣ 1 m and IgA-␣ 1 m showed that the cleavage involved the C-terminus (see above), the unpaired Cys34 residue (in the case of IgA-␣ 1 m), and the chromophores of ␣ 1 m, whereas the N-terminus as well as the carbohydrate moieties were intact ( Table 1) .
The reactivity of the unpaired sulfhydryl group (-SH) of Cys34 was investigated by alkylation with iodo[ 14 C]acetamide ( Figure 4 ; Table 1 ). Plasma-␣ 1 m could be alkylated with iodo[ 14 C]acetamide ( Figure 4A, lane 1) , indicating that the sulfhydryl group of Cys34 is Figure 2 . Release of the C-terminal tetrapeptide from ␣1m after cleavage with erythrocyte membranes and oxyhemoglobin. Plasma-␣1m (lanes 1 and 3) was incubated with erythrocyte membranes (lane 2) or oxyhemoglobin (lane 4) as described in "Materials and methods." After incubation for 3 hours at 37°C, ␣1m was purified from the reaction mixtures by affinity chromatography and gel chromatography on Sephacryl S-300. Purified ␣1m, 1 g to 3 g, was separated by SDS-PAGE in the presence of mercaptoethanol, staining, and Western blotting with antibodies against ␣1m or LIPR. The extremely heterogeneous chromophore of ␣ 1 m gives the protein a characteristic absorbance spectrum with a slowly declining absorbance throughout the upper UV and visible regions. It has been shown previously that urinary ␣ 1 m carries more chromophoric material than plasma-␣ 1 m, whereas IgA-␣ 1 m has almost no chromophore. 16, 27 Figure 5 shows that t-␣ 1 m from both plasma-and IgA-␣ 1 m had a higher absorbance in the upper UV and visible regions as compared with the uncleaved proteins. A shoulder in the absorbance was sometimes seen around 410 nm. t-␣ 1 m was also brown-colored in the test tube, whereas plasma-␣ 1 m is light yellow and IgA-␣ 1 m and pepsin-␣ 1 m are uncolored at the same concentrations.
␣ 1 m contains 4 tryptophan residues, 3 of which are located near the entrance of the lipocalin pocket. 29 The tryptophan fluorescence spectra of free plasma-␣ 1 m, pepsin-␣ 1 m, and t-␣ 1 m displayed emission maxima at 337, 338, and 345 nm, respectively (not shown). This shows that the local environment around the 4 tryptophan residues is more polar in t-␣ 1 m as compared with free plasma-␣ 1 m and pepsin-␣ 1 m (ie, the ␣ 1 m part of IgA-␣ 1 m).
The carbohydrate portion of ␣ 1 m, 2 N-linked and one O-linked oligosaccharide, 30 was intact after the cleavage as determined by investigation with specific endoglycosidases and lectins (Table 1) .
Cleaved ␣ 1 -microglobulin in urine
Due to its small size, ␣ 1 m is passed from the blood to the primary urine via glomerular filtration. A small part escapes tubular reabsorption and is excreted in the urine. It was shown that normal urine contains t-␣ 1 m, lacking C-terminal LIPR, and full-length ␣ 1 m ( Figure 6, lanes 4-6) . Furthermore, an increased t-␣ 1 m fraction was seen in urine from patients with hemolytic disorders (Figure 6,  lanes 1-3) , suggesting a relationship to pathologic erythrocyte destruction. This indicates that the cleavage of ␣ 1 m is a normally occurring biologic process and that t-␣ 1 m may be produced during hemolysis in vivo.
Binding and degradation of heme
The shoulder in the absorbance spectrum of freshly prepared t-␣ 1 m ( Figure 5 ) even after gel chromatography suggests the presence of heme, which has a characteristic absorbance peak at 405 nm to 415 nm called the Soret band. This prompted an investigation of a possible interaction among ␣ 1 m, t-␣ 1 m, and heme. Equimolar amounts of plasma-␣ 1 m, t-␣ 1 m, human serum albumin, and orosomucoid were incubated with [ 14 C]heme for various time periods, separated by SDS-PAGE, and analyzed by autoradiography ( Figure 7) . Both plasma-␣ 1 m and t-␣ 1 m displayed a binding of radiolabeled heme. Interestingly, more heme was bound to ␣ 1 m, especially to t-␣ 1 m, than to human serum albumin, a physiologic heme-binding protein. 31 Orosomucoid, a negative control from the Lipocalin superfamily, did not show any binding.
The heme binding was also investigated using hemoglobin insolubilized to Sepharose and oxidized to methemoglobin. Methemoglobin-Sepharose has been shown to bind heme less tightly than oxyhemoglobin and the metheme-group is transferred to albumin and other heme-binding proteins. 23 Plasma-␣ 1 m and t-␣ 1 m were incubated with methemoglobin-Sepharose and the absorbance spectrum of the supernatants showed a binding of metheme to both proteins ( Figure 8A,D) . The binding of heme was seen as a pronounced Soret band for both plasma-␣ 1 m and t-␣ 1 m. However, the time-dependence of the binding was radically different between the 2 ␣ 1 m-forms using this method. The proteins were incubated with methemoglobin-Sepharose for one hour, removed by centrifugation and their absorbance spectra then analyzed at different times. After 40 hours the Soret band of heme had disappeared almost completely from t-␣ 1 m ( Figure 8A) . Instead, the absorbance at lower wavelengths increased (300 nm-400 nm), yielding a heterogeneous spectrum that resembles the highly brown-colored urinary ␣ 1 m and recombinant ␣ 1 m from baculovirus-infected insect cells. 27 On the other hand, the absorbance spectrum of free plasma-␣ 1 m was stable during this time period ( Figure 8D ). The Methemoglobin-Sepharose (75 M) and t-␣ 1m (3 M) were incubated in PBS at 37°C for 1 hour. The sample was centrifuged and the absorbance spectrum of the supernatant measured at the indicated time intervals. The spectrum of a control sample (methemoglobin-Sepharose only) was subtracted. (B) Oxyhemoglobin (7 M) and t-␣1m (5 M) were incubated in PBS at 37°C for 1 hour. The t-␣1m was purified by affinity chromatography on a column of monoclonal anti-␣1m Affigel, concentrated, and the absorbance spectrum read after 0 and 5 hours. (C) Lysed erythrocytes (original cell volume diluted 1:1) and plasma-␣ 1m (40 M) were mixed and incubated at 37°C for 3 hours. The t-␣1m formed was purified by affinity chromatography on a column of monoclonal anti-␣ 1m Affigel and gel chromatography on Sephacryl S-300, concentrated, and the absorbance spectrum read after the indicated time intervals. (D) Methemoglobin-Sepharose (75 M) and plasma-␣1m (10 M) were incubated for 1 hour at 37°C. The sample was centrifuged and the absorbance spectrum of the supernatant measured at the indicated time intervals. rearrangement of the spectrum was also observed when t-␣ 1 m was incubated with soluble oxyhemoglobin ( Figure 8B ). Spectral analysis of t-␣ 1 m freshly isolated after incubation of plasma-␣ 1 m with lysed erythrocytes also revealed a decrease of the Soret band concomitant with an increase at 300 nm to 400 nm ( Figure 8C ). These results suggest a simultaneous heme degradation and chromophore formation in t-␣ 1 m. Figure 8B shows that heme is transferred from oxyhemoglobin to t-␣ 1 m and degraded. The time-dependence of the degradation was investigated more closely by continuously reading the absorbance at 410 nm in a t-␣ 1 m and oxyhemoglobin mixture using an excess of ␣ 1 m (molar ratio 8:1). Figure 9 shows that most of the absorbance at 410 nm disappeared within one hour, suggesting that the degradation is a rapid process.
Discussion
The results in this work show that plasma-␣ 1 m is proteolytically processed by ruptured erythrocytes and the C-terminal tetrapeptide LIPR is released. The cleavage is induced by hemoglobin and factors in erythrocyte membranes. The released, processed ␣ 1 m (t-␣ 1 m) binds and degrades heme with a concomitant formation of a yellow-brown chromophore strongly linked to the protein. The results thus suggest that ␣ 1 m has a role in heme catabolism after exposure of hemoglobin and erythrocyte membranes.
The processed t-␣ 1 m was found in urine together with the unprocessed form. In blood, ␣ 1 m is rapidly lost from the circulation by glomerular filtration. 32 Therefore, the t-␣ 1 m found in urine most likely has been filtered from plasma. This suggests that the cleavage described in this paper actually occurs in vivo. The finding is supported by a previous report that urinary ␣ 1 m is a mixture of full-length ␣ 1 m with 183 amino acids and a C-terminally truncated 179-amino acid form. 33 The proportion of t-␣ 1 m in urine should reflect to what extent ␣ 1 m is cleaved C-terminally in blood and/or tissues. It is therefore of interest to measure the ratio of full-length ␣ 1 m/t-␣ 1 m in urine of patients with for example hemolytic disorders as compared with healthy individuals. An initial approach to such an investigation is shown in Figure 6 . As expected, the ratio varies individually but a relatively higher amount of t-␣ 1 m is indicated in 2 of the 3 patients. Indeed, ␣ 1 m from the patient with mainly extravascular hemolysis is almost completely cleaved. Although it must be emphasized that this is not a clinical study, the preliminary findings are encouraging. Larger patient groups as well as a methodological fine-tuning are needed to better evaluate the potential clinical applications of the t-␣ 1 m/␣ 1 m ratio. Interestingly, the chromophore of urinary ␣ 1 m has a much more pronounced yellow-brown color and absorbance spectrum than plasma-␣ 1 m. The explanation for this could be that urinary ␣ 1 m partly consists of t-␣ 1 m, since it was shown here that the absorbance spectrum and color of the latter is similar to urinary ␣ 1 m.
The C-terminal processing of ␣ 1 m is apparently performed by factors found inside the erythrocytes. No sign of transport of ␣ 1 m across the erythrocyte membranes has been detected (not shown). It must therefore be concluded that in vivo processing only takes place after rupture of the red blood cells and exposure of the interior of the cell to ␣ 1 m. Purified hemoglobin displayed a processing activity at high concentrations and may be responsible for the cleavage activity found in the cytosol, where it is found in very high amounts. The membrane fraction showed a stronger specific processing activity than the cytosolic fraction. Hemoglobin is found deposited in various aggregated and oxidized forms on the cytosolic face of the erythrocyte membranes. 7 Therefore, it is possible that a variant of hemoglobin and other unknown membrane factors cause the C-terminal processing of ␣ 1 m.
The results suggest that the processed t-␣ 1 m induces a degradation of heme which is accompanied by a chromophore formation in the protein. It has been shown that the chromophore consists of covalent modifications of Lys 92, 118, and 130. According to molecular modeling of ␣ 1 m these residues are located semiburied at the entrance of the lipocalin pocket. 16, 29 It is possible that heme binds to the lipocalin pocket and induces the chromophore formation either as a direct precursor or by a reaction mechanism in which the chromophore is a by-product. Fluorescence analysis suggests that the tryptophan residues are more exposed to the hydrophilic environment in t-␣ 1 m. Interestingly, 3 of the 4 tryptophan residues are located around the entrance of the lipocalin pocket. It may be speculated that the C-terminal tetrapeptide is located close to the entrance of the pocket and that its proteolytic removal initiates heme degradation by exposing reactive side groups.
IgA-␣ 1 m may be regarded as a depot of ␣ 1 m from which ␣ 1 m is released and processed locally as soon as the erythrocyte ruptures. The size of IgA-␣ 1 m prevents the molecule from glomerular filtration and loss from the circulation. The release of ␣ 1 m from IgA and the C-terminal processing are probably 2 separate reactions requiring separate cofactors. The former reaction involves a reduction of the disulfide bond between Cys34 on ␣ 1 m and the Cys residue on the ␣-chain. The bond is unusually reduction-resistant and it has previously not been possible to break the bind in vitro. It was shown here that Cys34 on t-␣ 1 m is reduced and presents a free thiol group. According to the structural ␣ 1 m-model this residue is exposed and located on a flexible omega-loop near the entrance to the pocket. Cys34 has previously been shown to be attached to chromophore substances, 34 and it is possible that it is involved in the heme-binding and chromophore formation. Other heme-binding proteins have been shown to bind the heme group via an unpaired Cys residue; for instance, proteins carrying a so-called heme regulatory motif (HRM), such as the bacterial iron response regulator protein. 35 This work indicates that ␣ 1 m has a role in heme catabolism. Heme oxygenase, first described by Tenhunen et al, 36 is an intracellular enzyme that catalyzes the degradation of heme to biliverdin, CO, and free iron. 37 Heme oxygenase is membranebound and found in microsomes and it may be speculated that its diverse functions-heme degradation, iron utilization, and production of the powerful antioxidant biliverdin-are to be executed within the cells. ␣ 1 m, on the other hand, is found extracellularly in most organs [38] [39] [40] and is therefore expected to execute its tentative heme-degradation functions outside the cells. The presence of contaminations of heme oxygenase in the t-␣ 1 m preparations would have explained their heme-degradative properties. However, no trace of heme oxygenase was found using commercial antibodies to the protein in Western blotting, suggesting that the effects indeed were caused by t-␣ 1 m.
Several heme-binding and antioxidative substances are present in plasma, for example, albumin, hemopexin, vitamin E, and ascorbic acid. It is therefore not likely that the heme-binding and degradation properties of ␣ 1 m are primarily intended for free hemoglobin in plasma. More likely targets for these properties of ␣ 1 m are extravascular ruptured erythrocyte membranes. The oxidized forms of precipitated hemoglobin, free heme, and iron found on the cytosolic face of erythrocyte membranes are highly toxic to neighboring tissue. A role of ␣ 1 m could therefore be to protect against the exposed heme on the erythrocyte membranes, especially during extravascular hemolysis or massive intravascular hemolysis, where these plasma antiheme factors are not available in sufficient amounts.
Both free monomeric ␣ 1 m and high-molecular-weight ␣ 1 m have been found widely distributed in extravascular compartments. [38] [39] [40] IgA-␣ 1 m has been isolated from the placenta. 40 Interestingly, a truncated form of ␣ 1 m with an apparent molecular mass around 30 kd was observed associated with a placenta membrane fraction. This ␣ 1 m variant may be identical to t-␣ 1 m, the activation product of erythrocyte membranes, described in this paper. Indeed, it can be speculated that an activation of free ␣ 1 m and IgA-␣ 1 m takes place in ruptured tissue cells, for instance during inflammation and necrosis. Instead of hemoglobin, however, which is confined to erythrocytes, ␣ 1 m may interact with other heme-binding proteins such as cytochrome c in tissue cells. The t-␣ 1 m found in urine may very well originate from extravascular tissue rather than blood, since the protein was shown to be rapidly transported between the 2 compartments. 41 It remains to be shown, however, whether ␣ 1 m can be processed and activated by all cells.
